Patents
US 9132137 B2: Graduated estrogen contraceptive
- Granted
- 2015-09-15
- Filed
- 2010-11-16 application 12947397
- Type
- Utility · 10 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the reduction or elimination of estrogen in the initial phase is disclosed. Also described is a contraceptive kit that may be used to practice the method of the invention.
Source: PVGPATDIS, file of 2026-04-10 (ipg150915.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Warner Chilcott Company, LLC 27 patents | US company or organization | Fajardo, PR | WARNER CHILCOTT COMPANY, LLC State business registration EXACT high confidence: identical full name and state WARNER CHILCOTT PLC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Roger M. Boissonneault | Long Valley, NJ | 5 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/565 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P3/02 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2021-09-27 | Assignment Assignment of assignor's interest | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED signed 2019-11-29 | ALLERGAN THERAPEUTICS LLC MADISON, NJ | 57605/461 | PASDL, file of 2026-10-15 |
| 2018-02-22 | Correction Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment. | WARNER CHILCOTT COMPANY, LLC signed 2015-12-31 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 17 | 45417/593 | PASDL, file of 2026-10-15 |
| 2016-09-29 | Assignment Assignment of assignor's interest | WARNER CHILCOTT COMPANY, LLC signed 2015-12-31 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 17 | 40183/129 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.